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478a Tuesday, February 10, 2015imaging macromolecular protein complexes with single particle averaging
methods. However, the ability to obtain fluorescence images within a single mo-
lecular complex that allows the study of molecular heterogeneity and low copy
number complexes is still challenging, and remains an important goal for the
future development of super-resolutionmicroscopy.We here report early results
towards this goal of ‘‘single-molecule digital imaging’’ using DNA-PAINT.We
introduced three technical advances, including better localization accuracy by
obtainingmore photons per binding/blinking event, a novel template-based drift
correction algorithm, and wide-range tuning of blinking duty cycles for high-
density imaging. We demonstrated our approach to obtain molecular-scale res-
olution on a synthetically designed DNA origami nanostructure, which is made
of closely packed (spaced 5 nm apart) DNA molecules with imaging sites,
arranged in a ‘‘digital’’ grid pattern. Using small molecule-based oligonucleo-
tide labeling or genetically encoded tags, our imaging technology could achieve
molecular resolution within single-molecule complexes. It could be applied to a
wide range of biological and biomedical applications including the analysis of
densely packed cell surface receptor clusters, cytoplasmic signaling pathways,
or genomic organization and short-range interactions.
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Chronic kidney disease (CKD) arises from a diverse list of renal injuries. Renal
fibrosis is considered to be the final common pathway for most forms of CKD
and involves glomerular sclerosis and/or interstitial fibrosis. Because of that
there is great interest in identifying renal fibrosis in the early stages of CKD
to prevent progression. Unilateral ureteral obstruction (UUO) is a well-
described model of CKD and renal fibrosis. Kidney injury and fibrosis usually
are assessed by histology. Histological methods include Picro-Sirius Red stain-
ing, Masson’s Trichrome staining or immunohistochemistry for collagen iso-
forms. Quantitation of fibrosis using histologic techniques may be difficult
due to variability in staining and pathologist scoring. The goal of this study
is to compare histologic measures of renal fibrosis to Fluorescence Lifetime
Imaging (FLIM) and Second Harmonic Generation (SHG) techniques in our
deep tissue imaging microscope called DIVER. Male C57Bl6 mice were
subjected to UUO of right kidney. At 21 days, both kidneys were collected,
fixed, and paraffin-embedded. The uninjured left kidney was used as a control.
Serial sections of both kidneys were analyzed by Picro-Sirius Red staining or
FLIM with SHG. Quantification of a whole kidney section from the Picro-
Sirius Red staining showed 34.3250.99% area of fibrosis in the left kidney
compare to 5.5551.07% in the control kidney. Using the Phasor approach to
FLIM, comparisons between the two kidneys show that the auto fluorescence
lifetime signature give rise to two well separate phasor clusters. Quantification
of ten different fields of view for each kidney from SHG suggests the presence
of more collagen I in the diseased kidneys (17.4454.21% compared to
2.5951.98% control kidney). Finally the combined FLIM and SHG images
let us create a criterion to separate fibrosis directly from the microscope images.
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Confocal microscopes with multiphoton excitation and non-descanned detec-
tion (NDD) can penetrate deep into tissue. The combination with Fluorescence
Lifetime Imaging (FLIM) extends the capability of such an instrument for con-
centration measurements of specific molecules, superior discrimination against
autofluorescence as well as time resolved FRET (FLIM FRET).
For optimal detection efficiency the fluorescence light is collected directly above
the objective and guided to an Hybrid PMA detector combining GaAsP cathode
sensitivitywith excellent timing performance. TheNDDbased FLIMadapter re-
places the standard objective holder and is easy to mount. A modular detection
assembly allows to perform both confocal and NDD FLIM measurements.
The fluorescence lifetime of fluorophores is strongly dependent on their photo-
physical properties and local environment. Together with the emission profile
detected in different spectral channels the fluorescence decay can act as a finger-
print for a dye in a specific environment.We present a pattern-matching analysis
technique that allows to identify selected patterns consisting of fluorescence de-cays in different spectral excitation and detection channels. The technique is
easy to apply and allows for an excellent separation of different fluorophores,
changes of fluorescence parameters due to differences in the environment as
well as their discrimination from autofluorescence in biological samples.
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Every year millions of people in the United States are affected by skin cancer,
and like other cancers, the key to an effective treatment is early detection and
monitoring of disease progression. To this end, we have used intensity-, time-,
and wavelength-resolved multiphoton microscopy to measure changes in
cellular metabolism. By analyzing the fluorescence emission of metabolic
coenzymes such as the reduced form of Nicotinamide Adenine Dinucleotide
(NADH) and the oxidized form of flavin cofactors, slight changes in the
mitochondrial microenvironment and cellular metabolism can be quantified.
We used dual-channel fluorescence lifetime imaging (FLIM) to quantify meta-
bolic changes both within and between high- and low-HER2 expressing squa-
mous cell carcinoma cell lines (SCC-74B and SCC-74A, respectively).
Chemically-induced changes in the metabolic state led to measureable changes
in lifetime distributions and fluorescence intensities within each cell line. In
addition, SCC-74A and 74B could clearly be distinguished on the basis of
the fluorescence intensity dynamic range (difference between uncoupled and
inhibited metabolic states) and lifetime distributions. The metabolic imaging
technique has also been adapted to living skin in vivo. In particular, fluores-
cence signals originating from metabolically active and in-active sources are
identified and separated based on a combination of the two-photon-excited fluo-
rescence excitation/emission spectra and second harmonic generation (SHG).
This study was conducted at the Creighton University Integrative Bio-Imaging
Facility (CU-IBIF) and was supported by NIH DC 02053, NSF-EPSCoR EPS-
0701892 (CFD 47.076), NIH P20 RR16469 (NCRR) and 5P20GM103427
(NIGMS) aswell as theFerlicSummerResearchProgramatCreightonUniversity.
2413-Pos Board B550
Mapping P53 Alterations in Metabolism upon DNA Damage using the
Phasor/FLIM and Number & Molecular Brightness Analysis
Michelle A. Digman, Swathi Bagilthaya.
Biomedical Engineering, University of California, Irvine, Irvine, CA, USA.
p53 is a tumor suppressor protein that regulates target genes involved in DNA
damage migation and repair. If cells become stressed due to DNA damage,
p53 will induce genes that trigger cell cycle arrest and/or apoptosis. p53 has a
dual role in promoting oxidative phosphorylation (oxsphos) and glycolysis
upon cellular stress. However, the metabolic function of p53 has not been fully
explored. p53 metabolic activities may play an important role in normal growth,
development, and tumor suppression, it might also be misused to help promote,
rather than hinder, tumor development. To further assess p53 activity, we inves-
tigated the effect of metabolic changes under the same conditions and tested if
the concentration of p53 influences the balance between apoptosis and DNA
repair. We used the fluorescent lifetime imaging microscopy (FLIM) phasor
approach to detect changes in oxsphos and glycolysis. Overall our data show
the formation of p53 protein near the nucleolus and in areas near the inner re-
gions of the nucleus. We also show that upon DNA damage the concentration
of p53 increases by a factor of two independent of initial expression levels.
The FLIM/Phasor data show that low concentrations of p53 is enough to trigger
glycolytic response in the nucleus of the cells upon DNA damage with Cisplatin
and under high expression levels, a new lifetime phasor cluster is detected. This
new lifetime correlateswith dead phenotype cells andmay be a new ‘‘apoptotic’’
lifetime signal. In addition, we are able to visualize the sub-nuclear spatial local-
ization of p53 tetramers upon DNA damage with cisplatin and obtain spatial-
temporal malls of cellular localization and dynamics. This work is supported
in part by NIH grants P50 GM076516 and P41 GM103540.
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The post-synaptic area of the inhibitory synapse is characterized by sub-
resolved clusters of the scaffold protein Gephyrin [1] that anchors GABAA
